GB Sciences, Inc. (GBLX)

GB Sciences Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Selling, General & Admin	0.75	1.16	1.18	1.05	1.65	5.74
Research & Development	0.26	0.26	0.49	0.82	0.35	-
Operating Expenses	1.02	1.42	1.67	1.87	2	5.74
Operating Income	-1.02	-1.42	-1.67	-1.87	-2	-5.74
Interest Expense	-0.2	-0.22	-0.18	-0.47	-1.29	-1.11
Other Non Operating Income (Expenses)	-	-	0.1	0.01	-0.65	-0.18
EBT Excluding Unusual Items	-1.21	-1.64	-1.75	-2.33	-3.94	-7.03
Gain (Loss) on Sale of Assets	-	-	-	5.19	-	4.39
Asset Writedown	-0	-0.04	-2.37	-	-	-
Other Unusual Items	0.09	0.32	-	-3	0.6	-2.11
Pretax Income	-1.13	-1.36	-4.13	-0.15	-3.33	-4.75
Earnings From Continuing Operations	-1.13	-1.36	-4.13	-0.15	-3.33	-4.75
Earnings From Discontinued Operations	-	-	-	-0.38	-0.39	-8.36
Net Income to Company	-1.13	-1.36	-4.13	-0.53	-3.73	-13.11
Minority Interest in Earnings	-	-	-	-	-	0.74
Net Income	-1.13	-1.36	-4.13	-0.53	-3.73	-12.37
Preferred Dividends & Other Adjustments	0.01	0.28	-	-	-	-
Net Income to Common	-1.14	-1.64	-4.13	-0.53	-3.73	-12.37
Shares Outstanding (Basic)	406	397	358	318	285	258
Shares Outstanding (Diluted)	406	397	358	318	285	258
Shares Change (YoY)	5.59%	10.90%	12.63%	11.37%	10.35%	23.34%
EPS (Basic)	-0.00	-0.00	-0.01	-0.00	-0.01	-0.05
EPS (Diluted)	-0.00	-0.00	-0.01	-0.00	-0.01	-0.05
Free Cash Flow	-0.59	-0.98	-1.53	-1.87	-2.19	-4.48
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.01	-0.01	-0.02
EBITDA	-1.02	-1.42	-1.61	-1.8	-1.95	-5.62
D&A For EBITDA	0	0	0.06	0.07	0.05	0.13
EBIT	-1.02	-1.42	-1.67	-1.87	-2	-5.74

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.